MARKET

BFRG

BFRG

BULLFROG AI HLDGS INC
NASDAQ
1.130
-0.020
-1.74%
After Hours: 1.139 +0.009 +0.79% 17:17 12/05 EST
OPEN
1.180
PREV CLOSE
1.150
HIGH
1.200
LOW
1.110
VOLUME
72.82K
TURNOVER
--
52 WEEK HIGH
4.840
52 WEEK LOW
0.8036
MARKET CAP
12.89M
P/E (TTM)
-1.6292
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BFRG last week (1124-1128)?
Weekly Report · 4d ago
Weekly Report: what happened at BFRG last week (1117-1121)?
Weekly Report · 11/24 10:34
Nutex Health Soars 21% After Hours On Revenue Surge; Biotech Peers Join Tuesday Gainers
NASDAQ · 11/19 04:44
Bullfrog AI publishes whitepaper on AI in Bioinformatics
TipRanks · 11/18 15:00
BullFrog AI Unveils Whitepaper Showcasing AI Platform for Drug Discovery
Reuters · 11/18 14:19
Weekly Report: what happened at BFRG last week (1110-1114)?
Weekly Report · 11/17 10:35
Weekly Report: what happened at BFRG last week (1103-1107)?
Weekly Report · 11/10 10:32
'There will be no federal bailout for AI. The U.S. has at least 5 major frontier model companies. If one fails, others will take its place.' -Trump AI Official David Sacks
Benzinga · 11/06 17:00
More
About BFRG
Bullfrog AI Holdings, Inc. is a technology-enabled drug development company. The Company is focused specifically on advanced artificial intelligence/machine learning (AI/ML) analysis of complex data in the advancement of medicine. The Company’s platform technology, bfLEAP, is an analytical AI/ML platform that is a potentially disruptive tool for the analysis of pre-clinical and/or clinical data sets, such as the robust pre-clinical and clinical trial data sets being generated in translational research and development and clinical trial settings. The platform can capture the genetic and physical characteristics of patients in an unbiased manner and contextualize them against other disparate data sources from patients. Its siRNA targets Beta2-spectrin in the treatment of human diseases, such as hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis. Mebendazole is focused on targeting Glioblastoma.

Webull offers Bullfrog AI Holdings Inc stock information, including NASDAQ: BFRG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BFRG stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BFRG stock methods without spending real money on the virtual paper trading platform.